Security key
75383L102
Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)
CUSIP: 75383L102
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 47,779,015
- Total 13F shares
- 28,444,042
- Share change
- +1,923,507
- Total reported value
- $581,877,476
- Price per share
- $20.48
- Number of holders
- 55
- Value change
- +$37,552,009
- Number of buys
- 37
- Number of sells
- 17
Report period
Q3 2024
Institutions
55
Top holders
10
RAPP full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Rapport Therapeutics, Inc. SEC filings
Rapport Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75383L102
Recent filing periods:
Top shareholders of RAPP - Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
10%
|
4,983,351
|
$115,912,745 | — | 30 Jun 2024 | |
| ARCH Venture Management, LLC |
13F
|
Company |
7.8%
|
3,728,738
|
$86,730,446 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
6.2%
|
2,940,283
|
$68,390,983 | — | 30 Jun 2024 | |
| Capital International Investors |
13F
|
Company |
5.4%
|
2,602,531
|
$60,534,871 | — | 30 Jun 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
5.2%
|
2,498,051
|
$58,104,666 | — | 30 Jun 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
4.1%
|
1,951,562
|
$45,393,332 | — | 30 Jun 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
3.2%
|
1,535,151
|
$35,708,000 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.8%
|
1,360,605
|
$31,648,000 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.3%
|
1,090,858
|
$25,373,357 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.6%
|
748,183
|
$17,402,737 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
592,458
|
$13,213,659 | — | 30 Jun 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.73%
|
350,000
|
$8,141,000 | — | 30 Jun 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.44%
|
208,910
|
$4,373,322 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.36%
|
171,100
|
$3,979,786 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.24%
|
116,782
|
$2,716,349 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.21%
|
101,522
|
$2,361,402 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.16%
|
75,516
|
$1,756,502 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
0.15%
|
70,000
|
$1,628,200 | — | 30 Jun 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.15%
|
70,000
|
$1,628,200 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.15%
|
70,000
|
$1,628,200 | — | 30 Jun 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
50,000
|
$1,163,000 | — | 30 Jun 2024 | |
| LMR Partners LLP |
13F
|
Company |
0.1%
|
50,000
|
$1,163,000 | — | 30 Jun 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.08%
|
40,000
|
$930,400 | — | 30 Jun 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.07%
|
34,731
|
$807,843 | — | 30 Jun 2024 | |
| SOROS FUND MANAGEMENT LLC |
13F
|
Company |
0.06%
|
30,000
|
$697,800 | — | 30 Jun 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.04%
|
20,000
|
$465,200 | — | 30 Jun 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
16,345
|
$380,185 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
13,000
|
$302,380 | — | 30 Jun 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.02%
|
10,000
|
$232,600 | — | 30 Jun 2024 | |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP |
13F
|
Company |
0.02%
|
10,000
|
$228,600 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
9,400
|
$218,644 | — | 30 Jun 2024 | |
| Sandia Investment Management LP |
13F
|
Company |
0.01%
|
5,000
|
$116,300 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,127
|
$72,734 | — | 30 Jun 2024 | |
| Tidemark, LLC |
13F
|
Company |
0%
|
1,088
|
$25,307 | — | 30 Jun 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
225
|
$5,000 | — | 30 Jun 2024 | |
| ARCH Venture Partners XII, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,728,738
|
$37,212,805 | — | 10 Jun 2024 | |
| Bradley S. Galer |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
321,244
mixed-class rows
|
$1,970,311 | — | 06 Jun 2024 |
Institutional Holders of Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP) as of Q3 2024
As of 30 Sep 2024,
Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,444,042 shares.
The largest 10 holders included
FMR LLC, ARCH Venture Management, LLC, Cormorant Asset Management, LP, Capital International Investors, JOHNSON & JOHNSON, Sofinnova Investments, Inc., T. Rowe Price Investment Management, Inc., GOLDMAN SACHS GROUP INC, ALLIANCEBERNSTEIN L.P., and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
55
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
35
Q3 2024 holders
55
Holder diff
20
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.